Cancer Summit

Cancer Prevention, Screening, and Public Health Strategies

Cancer prevention and early detection are critical components of reducing global cancer burden, focusing on lifestyle interventions, vaccination programs, and population-based screening initiatives. Current trends emphasize preventive strategies such as HPV and hepatitis B vaccination to lower infection-related cancer incidence, tobacco cessation campaigns, dietary and exercise interventions, and risk-reduction counseling for genetically predisposed individuals. Advances in screening technologies, including low-dose CT for lung cancer, mammography for breast cancer, colonoscopy and fecal immunochemical tests for colorectal cancer, and liquid biopsy platforms for multi-cancer detection, are enabling earlier diagnosis and improved survival rates. Public health strategies are increasingly integrating precision prevention by using genetic and biomarker profiling to identify high-risk populations, optimize screening frequency, and personalize intervention programs. Digital health tools, mobile applications, and AI-driven risk assessment models are facilitating wider outreach, education, and adherence to preventive measures, particularly in underserved regions. Challenges remain in ensuring equitable access, addressing socioeconomic disparities, and achieving high participation rates in national screening programs. This session will explore emerging research, innovative screening methods, policy initiatives, and public health strategies that promote cancer prevention, early detection, and population-level interventions, ultimately aiming to reduce incidence, improve outcomes, and enhance global cancer control efforts.